Seneca Valley virus 3C
3C protease
Seneca valley virus (SVV)
degradation
hnRNP A1
replication
Journal
Virulence
ISSN: 2150-5608
Titre abrégé: Virulence
Pays: United States
ID NLM: 101531386
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
entrez:
20
12
2021
pubmed:
21
12
2021
medline:
16
4
2022
Statut:
ppublish
Résumé
Seneca Valley virus (SVV) is a recently-identified important pathogen that is closely related to idiopathic vesicular disease in swine. Infection of SVV has been shown to induce a variety of cellular factors and their activations are essential for viral replication, but whether heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) involved in SVV replication is unknown. The cytoplasmic redistribution of hnRNP A1 is considered to play an important role in the virus life cycle. Here, we demonstrated that SVV infection can promote redistribution of the nucleocytoplasmic shuttling RNA-binding protein hnRNP A1 to the cytoplasm from the nucleus, whereas hnRNP A1 remained mainly in the nucleus of mock-infected cells. siRNA-mediated knockdown of the gene encoding hnRNP A1 attenuated viral replication as evidenced by decreased viral protein expression and virus production, whereas its overexpression enhanced replication. Moreover, infection with SVV induced the degradation of hnRNP A1, and viral 3 C protease (3 C
Identifiants
pubmed: 34923914
doi: 10.1080/21505594.2021.2014681
pmc: PMC8923066
doi:
Substances chimiques
Heterogeneous Nuclear Ribonucleoprotein A1
0
Peptide Hydrolases
EC 3.4.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3125-3136Références
Adv Exp Med Biol. 1998;440:227-34
pubmed: 9782285
J Gen Virol. 2008 Oct;89(Pt 10):2540-2549
pubmed: 18796723
J Cell Sci. 2009 Oct 15;122(Pt 20):3799-809
pubmed: 19789179
PLoS One. 2017 Nov 16;12(11):e0188214
pubmed: 29145464
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
Virology. 2019 Nov;537:254-263
pubmed: 31539773
FEBS Lett. 2005 May 9;579(12):2623-8
pubmed: 15862300
Antiviral Res. 2018 Dec;160:183-189
pubmed: 30408499
EMBO J. 2001 Jan 15;20(1-2):240-9
pubmed: 11226174
Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1055-65
pubmed: 20153290
Nucleic Acids Res. 2020 Oct 9;48(18):10479-10499
pubmed: 32960212
Virology. 2004 Mar 15;320(2):195-205
pubmed: 15016543
J Gen Virol. 2008 May;89(Pt 5):1265-1275
pubmed: 18420805
Pathogens. 2020 Jun 04;9(6):
pubmed: 32512928
Virology. 2015 May;479-480:457-74
pubmed: 25818028
J Mol Biol. 1989 Jun 5;207(3):491-503
pubmed: 2760922
J Virol. 2017 Jul 27;91(16):
pubmed: 28566380
J Virol. 1999 Mar;73(3):2193-200
pubmed: 9971802
Front Microbiol. 2019 May 29;10:1202
pubmed: 31191506
J Natl Cancer Inst. 2007 Nov 7;99(21):1623-33
pubmed: 17971529
Mol Biol Cell. 2007 Dec;18(12):5048-59
pubmed: 17898077
Biochem J. 2010 Sep 15;430(3):379-92
pubmed: 20795951
EMBO J. 2000 Sep 1;19(17):4701-11
pubmed: 10970862
J Virol. 2005 Mar;79(6):3254-66
pubmed: 15731220
Oncogene. 2010 Mar 25;29(12):1821-34
pubmed: 20101230
J Mol Biol. 2017 Sep 15;429(19):2841-2858
pubmed: 28625847
Can Vet J. 2008 Jan;49(1):84-5
pubmed: 18320985
PLoS One. 2019 Sep 9;14(9):e0221048
pubmed: 31498791
Front Immunol. 2020 Sep 29;11:577838
pubmed: 33133097
J Virol. 2019 Sep 30;93(20):
pubmed: 31375578
Viruses. 2017 Jul 03;9(7):
pubmed: 28671611
J Virol. 2001 Jun;75(11):5009-17
pubmed: 11333880
Structure. 2008 Oct 8;16(10):1555-61
pubmed: 18940610
Mol Cell Neurosci. 2013 Sep;56:436-46
pubmed: 23247072
J Virol. 2009 Jun;83(12):6106-14
pubmed: 19339352
Cell. 2009 Feb 20;136(4):701-18
pubmed: 19239890
J Virol. 2015 Jul;89(14):7064-78
pubmed: 25926642
Virus Res. 2015 May 4;203:84-91
pubmed: 25865411
J Virol. 2008 Feb;82(4):1647-55
pubmed: 18045934
J Virol. 2018 Nov 27;92(24):
pubmed: 30282705
Viruses. 2018 Mar 13;10(3):
pubmed: 29534017
Front Immunol. 2019 Mar 13;10:363
pubmed: 30918505
Virology. 2019 Sep;535:122-129
pubmed: 31299488
J Virol. 2020 Sep 29;94(20):
pubmed: 32759322
J Biol Chem. 2010 Sep 10;285(37):28796-805
pubmed: 20622012
Adv Exp Med Biol. 2007;623:123-47
pubmed: 18380344